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ABSTRACT 
Human nephrocystin is a protein associated with juvenile 
nephronophthisis, an autosomal recessive inherited kidney 
disease responsible for chronic renal failure in children. It 
contains an SH3 domain involved in signalling pathways 
controlling cell adhesion and cytoskeleton organisation. The 
solution structure of this domain was solved by triple 
resonance NMR spectroscopy. Within the core, the structure is 
similar to those previously reported for other SH3 domains, but 
exhibits a number of specific non-canonical features within the 
polyproline ligand binding site. Some of the key conserved 
residues are missing and the N-Src loop exhibits an unusual 
twisted geometry, which results in a narrowing of the binding 
groove. This is induced by the replacement of a conserved Asp, 
Asn or Glu residue by a Pro at one side of the N-Src loop. A 
systematic survey of other SH3 domains also containing a Pro at 
this position reveals that most of them belong to proteins 
involved in cell adhesion or motility. A variant of this 
domain, which carries a point mutation causing nephronophthisis 
was also analysed. This change, L180P, although it corresponds 
to a non-conserved and solvent-exposed position, causes a 
complete loss of the tertiary structure. Similar effects are 
also observed with the L180A variant. This could be a context-
dependent effect resulting from an interaction between 
neighbouring charged side chains.  
Abbreviations : DQF-COSY, Double quantum filtered spectroscopy, 
GST, Glutathion-S-transferase; HSQC, Heteronuclear single 
quantum correlation; NOESY, Nuclear Overhauser effect 
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spectroscopy; r.m.s.d., Root mean square deviation; SH3, src-
homology 3 domain; TOCSY, Total correlation spectroscopy 
INTRODUCTION 
Familial juvenile nephronophtisis (NPH) is an autosomal 
recessive and genetically heterogeneous tubulo-interstitial 
nephropathy responsible for 6–8% of end stage renal disease in 
childhood1. The first sign of the disease is polyuria, followed 
by progressive deterioration of renal function during 
childhood. NPH is characterised by tubular atrophy, abnormal 
thickening of the tubular basement membrane, interstitial 
fibrosis, and cyst formation at the cortico-medullary junction. 
NPH may be associated with extra-renal manifestations such as 
retinitis pigmentosa, congenital ocular motor apraxia, liver 
fibrosis and bone anomalies.  
The gene mutated in most patients is NPHP1, coding for the 
protein nephrocystin2,3, a 732-amino acid intracellular protein, 
which exhibits a segmented domain structure: An N-terminal 
predicted coiled-coil domain, an SH3 domain flanked by two 
glutamic acid-rich regions, and a highly conserved C-terminal 
“ nephrocystin homology domain ”  (NHD). NHD bears several 
functions among which dimer or oligomer formation, epithelial 
cell-cell junction targeting, interaction with filamins 4 , 
with the microtubule component beta-tubulin5 , and with 
nephrocystin-4, a recently identified protein involved in some 
cases of juvenile NPH 6,7. Nephrocystin, as well as 
nephrocystin-4 was shown to localize to the cell-cell junctions 
and to the primary cilia of renal tubular epithelial cells4,5,7.  
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The proteins that have been shown to interact with the 
nephrocystin SH3 domain are implicated in signalling pathways 
regulating cell adhesion processes and organisation of the 
cytoskeleton. Among them are p130Cas (Crk-associated 
substrate4) and Pyk28. Therefore, it seems likely that 
nephrocystin functions as a docking protein that might regulate 
the organization of the actin and microtubule cytoskeleton and 
maintain epithelial renal cell polarity4,5.  
Most of the patients with nephronophthisis have a large 
deletion in the NPHP1 gene 9. In addition, several point 
mutations have also been detected, including a leucine to 
proline change at position 180 within the SH3 domain. The 
present work addresses the question of nephrocystin SH3 domain 
structure, as a key to understand the adaptor function of this 
protein, and of the consequences of the L180P mutation on the 
protein structure and the onset of the disease.  
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MATERIALS AND METHODS 
SH3 Expression and purification 
The DNA region corresponding to codons 147-212 of the human 
NPHP1 gene was PCR-amplified and inserted into the GST 
(Glutathion-S-transferase) fusion vector pGEX-2T (Amersham). 
The resulting construct was transformed into E. coli BL21(DE3). 
After purification on glutathion agarose and subsequent 
thrombin cleavage, the nephrocystin SH3 domain/GST fusion 
protein was submitted to a final purification step by ion-
exchange chromatography (Source 15Q, Amersham). The resulting 
isolated SH3 domain was composed of an N-terminal Gly-Ser 
sequence, originating from the thrombin recognition site, 
followed by amino acids 147-212 of nephrocystin. For NMR 
studies, the 15N,13C doubly labelled SH3 domain was purified 
similarly from cells grown on Martek-9 CN medium (Spectra 
Stable Isotopes). The L180 mutations were engineered in the 
pGEX expression vector using the QuickChange mutagenesis kit 
(Stratagene). The DNA sequence of the mutant clones was 
verified. Variant GST-fusion proteins were expressed, purified 
and cleaved with thrombin, using the same protocol as for the 
wild-type SH3 domain. All SH3 samples were dissolved in 50 mM 
potassium phosphate, pH 6.5 (90% H2O:10% 
2H2O). Final protein 
concentrations were 1.0 to 1.5 mM 
NMR methods and structure calculations 
Spectra were recorded at 298 K on a Bruker Avance 600 NMR 
spectrometer equipped with a triple resonance inverse probe. 
Assignments were derived from two independent strategies, using 
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either the 3D HNCACB / CBCA(CO)NH pair of experiments10,11 or the 
3D 15N-NOESY-HSQC/15N-TOCSY-HSQC pair of experiments. Owing to 
the small size of the protein (only 60 observable spin 
systems), both approaches gave completely consistent sequential 
assignments, with no ambiguities. 
Distance restraints were extracted from either 15N or 13C NOESY-
HSQC experiments, both with a mixing time of 150 ms. Distances 
were classified as strong, medium or weak, and assigned upper 
limits of 2.5, 3.5 or 5 Å, respectively, and a correction of 
+0.5 Å was applied to NOEs involving methyl groups. No 
ambiguous restraints were used. ϕ dihedral angle restraints 
were extracted from the analysis of a 3D HNHA experiment12. 
Stereospecific identification of β-methylene proton and χ1 
angles were assigned from the combined analysis of the 3JNβ and 
3JHNHα extracted from HNHB
13
 and DQF-COSY experiments, 
respectively, and from the comparison of the relative 
intensities of the intra residual Hα−Hβ and HN-Hβ NOE 
crosspeaks. χ1 angles were constrained to lie within ± 60° of 
the identified rotamer. Initial conformers were generated with 
DIANA14, using a three stage REDAC strategy15 and structures with 
the lowest target function were refined by restrained simulated 
annealing using X-PLOR16, as previously described17. 
Molecular dynamics 
The mutant structure was constructed as follows. The P180 
mutation was introduced manually in the PDB file, and the 
structure was energy minimized in XPLOR, keeping all other 
atoms fixed and using a purely repulsive Van der Waals energy 
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term. The structure was then submitted to two successive short 
molecular dynamics simulations (2.5 ps each) at 300K under the 
parmallh3x  XPLOR forcefield 16, with the electrostatic term 
switched off. In the first run, all backbone atoms were 
constrained to their position in the wild type structure with a 
harmonic potential of strength kharm = 2 kcal/mol./Å2, whereas in 
the subsequent run, this harmonic potential was removed. No 
major structural changes were observed after this procedure. A 
final molecular dynamics run (4 ps) was then performed using 
the full potential, including electrostatics. Solvent shielding 
was crudely simulated by having a dielectric constant 
increasing linearly with distance (« rdie » option in XPLOR). 
The resulting mutant structure was finally energy minimized. 
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RESULTS AND DISCUSSION 
NMR assignment structure of the nephrocystin SH3 domain 
The SH3 domain from human nephrocystin was cloned, expressed 
and purified as described under materials and methods. Using a 
doubly 15N, 13C labelled sample, backbone proton, carbon and 
nitrogen NMR assignments were obtained using standard triple 
resonance experiments. Chain tracing was straightforward and 
allowed the unambiguous identification of residues T153 to E212 
(sequence shown in figure 1). The backbone amide groups of the 
eight first residues, including the exogeneous Gly-Ser 
sequence, could not be detected in HSQC type experiments, as 
they presumably exchanged too fast with the solvent and are 
most likely disordered. Assignments of backbone amide groups 
are shown in figure 1. Side chain resonances where identified 
from the combined analysis of HCCH-TOCSY 18 and 13C TOCSY-HSQC 
experiments 19. Proton assignments were essentially complete, 
with the exception of part of the side chains of E155, 
K184,W189, R204 and E212. Stereospecific assignments were 
obtained for 16 β-methylene protons and for all four valine 
methyl groups, by the combined analysis of HNHB , 15N and 13C 
NOESY-HSQC experiments 20.  
In establishing the structure, only residues 153 to 212 where 
considered. Experimental distance restraints were extracted 
from the analysis of heteronuclear NOESY experiments and ϕ and 
χ1 dihedral angles from the analysis of coupling constants and 
relative intra-residue NOE intensities. Finally, hydrogen bond 
restraints were included for slowly exchanging amide groups 
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which were involved in regular secondary structure elements. 
Overall, they consisted of 540 NOE-derived restraints (110 
intra-residue, 121 sequential, and 309 medium to long range 
restraints), 32 ϕ and 21 χ1 angle restraints and 30 hydrogen 
bond restraints. This corresponded to an average of 10.4 
constraints per residue.  
The structure of nephrocystin SH3 domain was calculated by a 
hybrid method combining initial structure generation in torsion 
angle space with the DIANA program14, followed by refinement 
with XPLOR16, as previously described 17. Two hundred initial 
structures were generated using DIANA and the 20 conformers 
with the lowest target function were retained for refinement 
with XPLOR. After the restrained simulated annealing stage, 
three of the resulting structures exhibited a high total energy 
and strong violations of several experimental restraints and 
were thus discarded. The final set of converged structures thus 
contains 17 conformers (PDB entry 1S1N), overlayed in figure 2. 
All of the 17 showed a correct stereochemistry, a good Van der 
Waals geometry  and satisfied the experimental restraints (see 
Table I). The r.m.s.d. over the entire set is 0.63 Å for 
backbone atoms and 1.09 Å for all heavy atoms. If the more 
disordered parts of the RT-Src and distal loops (residues 166-
168 and 195-197), as well as the first and the last two 
residues are excluded, then, the r.m.s.d drops to 0.46 Å for 
backbone atoms and 0.88 Å for all heavy atoms.  
Comparison with the structure of other SH3 domains 
The amino acid sequence of nephrocystin SH3 domain is 
substantially different from other SH3 domains with known 3D 
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structure, with sequence identity levels ranging from ~20 to 
40%. The closest match is with the first of the two c-Crk SH3 
(40 % sequence identity). Nevertheless, the overall structure 
of nephrocystin SH3 domain is very similar to the other SH3 
structures available in the Protein Data Bank 
(http://www.rcsb.org/pdb/). When superimposed with the crystal 
structure of the related c-Crk SH3 (PDB entry 1CKA21), the 
r.m.s.d. for all backbone atoms is 1.50 Å. The major 
differences between the two structures are located at the very 
tip of the RT-Src and N-Src loops (Figure 3). If these loop 
residues are removed from the computation, then the backbone 
r.m.s.d. drop to 0.79 Å, over 45 residues. Within the RT-loop, 
differences correspond to a small global outward movement of 
the peptide backbone, with only minor local changes. The 
slightly more “ closed ”  conformation of the c-Crk SH3 RT-loop 
could result from the presence of a bound peptide in the 
corresponding crystal structure. On the other hand, the 
conformation of the N-Src loop is quite different in the two 
structures, with the nephrocystin loop exhibiting a twisting 
“ S-shaped ” conformation around residues 185 and 186 (figure 
3). This difference in conformation is unambiguously supported 
by numerous NOEs, in particular involving the side chain of 
K185, which contacts those of W190 and T205. In c-Crk, the side 
chain of the residue corresponding to K185 (N94) points toward 
the opposite direction, with its Cγ atom more than 10 Å away 
from the residues corresponding to W190 and T205. The side 
chain of K185 is indeed unusually well defined and, because of 
its close proximity with W190 indole ring, it exhibits strongly 
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ring-current shifted γ CH2 resonances at –0.33 and –0.14 ppm 
(the two rightmost resonances, resolved in the 1D spectrum 
shown in figure 4). 
Specific sequence features of nephrocystin SH3 domain 
The primary sequence of the nephrocystin SH3 domain exhibits a 
few significant deviations from the consensus SH3 sequence22, 
all located within the ligand recognition site (shown in figure 
2, bottom). In order to investigate possible correlations 
between those and the specific structural features of 
nephrocystin SH3, a systematic sequence survey was performed. 
To this purpose, an extensive set of 1626 SH3 sequences was 
extracted from the Pfam database 
(http://www.sanger.ac.uk/Software/Pfam/, accession number 
PF00018). The first significant unusual feature of the 
nephrocystin SH3 ligand binding site is the presence of a 
glycine at position 161 (figure 2, bottom). This corresponds to 
position 8 in the standard SH3 numbering and is an aromatic 
residue in 88% of SH3 sequences (mostly Y or F). Its aromatic 
ring forms the “ ’floor”  of the P2 and P3 subsites
23
. 
Substitution of this residue by a glycine opens a cleft on the 
surface of the nephrocystin SH3 which could either allow for 
the binding of a bulkier side chain or accommodate a bending of 
the ligand backbone. This feature is highly specific, as only 8 
of the 1626 examined SH3 domains carried a glycine at this 
position, half of which correspond to the various available 
nephrocystin sequences.  
The other major unusual sequence feature of the nephrocystin 
SH3 domain is located within the N-Src loop of nephrocystin SH3 
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and correlates with the unusual conformation of this loop : it 
has a proline at position 186 (numbered 33 in the SH3 standard 
nomenclature22) which induces the observed kink in the backbone 
(figure 3). In 64 % of the analysed SH3 domains, at this 
position, either a Glu, Asp or Asn residue is normally found, 
making side chain contacts with the bound peptide22. In 
nephrocystin, the modified conformation of the N-Src loop 
narrows the ligand binding groove at the level of the P
-2 and P-4 
subsites23 and hence favours the binding of sequences with 
smaller side chains at either or both of these positions. 
Within the 1626 analysed SH3 sequences, 55 contained a proline 
which could be unambiguously aligned at this position. Among 
those, nephrocystin is currently the only one for which a 3D 
structure is available, but it is reasonable to assume that a 
number of those also exhibit the same twisted conformation of 
the N-Src loop induced by the proline residue. It was of 
interest to see whether this particular sequence feature within 
a key ligand recognition element of the SH3 could correlate 
with some functional feature of the corresponding proteins, via 
one or more specific targets of this protein interaction 
domain. A database search revealed that 43 of these 55 SH3 
belong to proteins with either identified or tentatively 
assigned functions. Interestingly, among those 43 proteins, 40 
are either directly or indirectly associated with the 
cytoskeleton and motility or adhesion : 5 nephrocystins, 9 type 
I myosins, 7 intersectins (involved in endocytosis, interact 
with dynamin and N-WASP via their SH3 domains 24), 4 
phospholipases C-γ (co-localise with actin via their SH3 
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domains25), 3 Fish (scaffolding proteins localized in actin-rich 
structures in Src-transformed cells 26), 2 P-dlg (homolog of 
Drosophila Discs-large protein, involved in cytoskeleton 
organisation, synaptic junctions and cell polarity 
maintenance27), 9 Nox proteins (phagocyte NADPH oxidase 
activation, these proteins have to be initially translocated to 
the site of phagocytosis at the plasma membrane, a process 
involving actin) and yeast RVS167 protein (involved in the 
regulation of actin distribution, cell polarity, morphology and 
budding28). This suggest that possibly, all these proteins can 
be addressed to active regions of the cytoskeleton via the 
interaction of their “atypical”  SH3 binding groove to one or 
more specific partners within the actin complex. 
 
The L180P mutation which causes nephronophtisis, strongly 
destabilises the nephrocystin SH3 structure 
One patient mutation causing nephronophtisis, L180P, has been 
mapped into nephrocystin SH3 domain 6. It corresponds to 
position 27 in the systematic SH3 sequence alignment 22, points 
toward the solvent and is neither part of the extensively 
characterised structural core nor located within the ligand 
recognition site. In order to assess the consequences of this 
mutation on the nephrocystin SH3 domain structure, the 
corresponding mutant protein was engineered by site-directed 
mutagenesis and expressed and purified as the wild-type. 1D 1H 
NMR data recorded on the L180P SH3 domain protein showed a 
dramatic change compared to the wild-type protein (figure 4). 
The mutant domain spectrum corresponds to that of an unfolded 
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protein, showing a very narrow amide spectral width, a 
coalescence of aliphatic resonances and no shifted methyl 
resonances. Accordingly, the 2D-NOESY spectrum was totally 
devoid of signals characteristic of protein tertiary structure, 
such as amide-amide contacts, or aromatic-methyl contact (not 
shown). Most backbone amide groups showed negative or vanishing 
heteronuclear 1H-15N NOEs (not shown) which is clearly 
indicative of very rapid motions of the backbone, as expected 
from an unfolded protein. 
Thus, the L180P mutation appears to completely destabilise the 
SH3 domain fold. Given the modular organisation of 
nephrocystin, it is therefore likely that it also holds in the 
context of the full-length protein. The mutant protein will 
therefore be unable to interact with its partners, such as 
p130Cas and Pyk2, and will possibly be more vulnerable to 
proteasome degradation, thereby explaining the loss of 
nephrocystin function. 
The observation that this mutation completely abolishes 
formation of the otherwise robust SH3 domain fold is quite 
surprising, since it corresponds to a non-conserved, solvent-
exposed position. L180 is however located within a β-strand and 
substitution by a proline residue might not be tolerated within 
the corresponding β-sheet. Accordingly, in the extensive 
alignment of 1623 SH3 domains available in the Pfam database, 
this position is quite variable, but never corresponds to a 
proline. In order to assess whether the observed effect was the 
result of the insertion of the proline within the β-strand or 
of the leucine side chain removal, a “milder ” L180A change 
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was also engineered and the corresponding SH3 variant was 
expressed and purified similarly. Most strikingly, its 1D 1H 
NMR spectrum exhibited an intermediate behaviour (figure 4), 
and can be interpreted as a mixture of a minor fraction of the 
folded wild-type SH3 and a major fraction of the unfolded 
state, similar to L180P mutant. This shows that, by itself, the 
leucine side chain at position 180 plays some critical role in 
the folding and/or the stability of the nephrocystin SH3 fold. 
To our knowledge, such a dramatic effect of a surface residue 
on the stability of SH3 domains has never been reported. 
Indeed, although numerous thorough studies have been performed 
on the SH3 model system for protein folding 29-33, most of those 
have so far been focused on residues forming the conserved 
structural core, either via their involvement in the 
hydrophobic core packing or through their contributions to the 
hydrogen bonding network. 
In order to investigate the L180P loss of structure effects, 
the consequences of this structural change were analysed by 
molecular modelling. After hand-constructing the mutation into 
the wild-type coordinates, the resulting structure was 
regularised with X-PLOR by performing a short molecular 
dynamics refinement followed by an energy minimisation, in the 
absence of electrostatics. At this stage, no steric clashes 
remained and the energy score was essentially identical to that 
obtained with the wild-type sequence. This indicated that the 
proline could in principle be quite easily accommodated within 
the scaffold of the native protein, with only marginal local 
changes to the structure. The fact that the L180A mutation also 
destabilised the SH3 was even more surprising, given that, in 
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that case, steric constraints cannot explain the effect and 
that, in some SH3 sequences, an alanine can be found at this 
position. This suggested that specific local environment of 
L180 in nephrocystin might contribute to this dramatic effect. 
Indeed, examination of the structure revealed that L180 is 
sandwiched between two oppositely charged residues, E156 and 
K193, located on the neighbouring β-strands. Thus, the bulky 
aliphatic side chain of L180 could act as an electrostatic 
“ insulator ” on the surface of nephrocystin SH3 (figure 5, 
left). In order to assess the influence of these charged 
residues on the stability of the SH3 fold, we performed a short 
molecular dynamics simulation of the L180P mutant model 
constructed above, but including the electrostatic term of the 
X-PLOR energy function. Although this was only a “crude”  
simulation, performed in vacuo, it does demonstrate that it is 
sterically possible for the two charged residues to come in 
close contact over the pyrrolidine ring of P180 and also most 
likely in the case of an even smaller side chain such as 
alanine, for the L180A mutant. This hypothesis is compatible 
with database analysis : within the 1626 SH3 sequences in Pfam, 
there are 58 other sequences which have a similar pattern with 
an acidic and a basic at the positions corresponding to E156 
and K193, respectively. The intervening residue has a rather 
bulky side chain in a large majority of cases, with Ile, Leu, 
Thr and Trp representing 90% of the observed residues at that 
position (compared to only 34% for the whole SH3 set). There is 
one single exception which carries an intervening Glycine 
between the two charged residue (entry Q7PYD8), corresponding 
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to an undocumented predicted gene from Anopheles Gambiae whole 
genome sequence. 
The L180P mutation could thus destabilise the SH3 fold by three 
non-exclusive mechanisms : (i) In the absence of a bulky 
insulating side chain, the movement of solvent-exposed E156 and 
K193 could twist the attached β-strands and perturb the 
delicate packing of the conserved hydrophobic core residues 
located on the opposite side of the β-sheet (L179, V181) 
thereby destabilising the overall folded structure. Indeed the 
residue equivalent to L179 in Fyn SH3, F26, has been shown to 
play an important role in the cooperativity of the folding 34. 
(ii) The L180P mutation is located very close to the diverging 
type II β-turn (residues 173-179 in nephrocystin SH3) which has 
been shown to be able to fold independently 35 and proposed to 
be a nucleation site for SH3 domain folding 36. The mutation 
and/or the electrostatic interaction between E156 and K193 
could kinetically interfere with the folding process and/or 
inhibit the standard folding pathway. (iii) P180 lacks the 
backbone amide proton which contributes to the stability of the 
β-barrel structure by making a hydrogen bond with carbonyl 
group of adjacent K193. The first two mechanisms also hold for 
the L180A variant and could thus explain the significant 
although less severe loss of stability observed for this 
variant. Overall, this suggests that the drastic 
destabilisation of the nephrocystin SH3 domain by the L180P or 
L180A mutations is a context-dependent effect. This is further 
supported by the observation that in a number of sequences, an 
alanine residue can be accommodated at this position, as for 
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instance in Pex13P SH3 domain structure (PDB 1NM737). But in 
those instances, the alanine is not located between ion-pair 
forming residues, such as E156 and K193 in nephrocystin. 
 
This study is the first to report the structure of an SH3 
domain of a protein involved in an inherited kidney disease. It 
reveals novel structural features within the ligand binding 
groove which will have important consequences for its 
recognition specificity and possibly for its targeting to 
cytoskeleton proteins. It clearly proves the pathogenic role of 
a missense mutation, L180P, found in a patient with juvenile 
NPH. Similar approaches could be further used to test other 
mutations in the nephrocystin SH3 domain, as well as to study 
the interaction of nephrocystin with potential SH3 ligands.  
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LEGEND TO THE FIGURES 
Figure 1 : Sequence and NMR assignment of nephrocystin SH3 
domain.  
Top : primary sequence of the recombinant nephrocystin SH3 
domain used for solution NMR studies. The amino acid numbers 
correspond to the whole length nephrocystin. The first two 
residues (GS) orginate from the thrombin cleavage site. 
Underlined is the SH3 domain sequence. These residues 
correspond to those which gave detectable signals in amide-
based experiments.  
Bottom : Assignment of backbone amide groups of nephrocystin 
SH3 domain. Shown is a 15N HSQC spectrum recorded on a 1.5 mM 
15N; 13C doubly labelled sample dissolved in 50 mM potassium 
phosphate, pH 6.5 (90% H2O:10% 
2H2O).  
 
Figure 2 : 3D Structure of nephrocystin SH3 domain 
Top : Superimposition of the 17 refined conformers of 
nephrocystin SH3 domain (PDB entry 1S1N). The backbone is shown 
in green. Selected well-defined side chains have been 
indicated. Conserved hydrophobic core residues are shown in red 
and other residues are shown in blue.  
Bottom : Ligand binding site of nephrocystin SH3 domain. 
Residues which are conserved or semi-conserved in most SH3 
sequences are shown in green. Residues which differ from the 
conserved SH3 consensus are shown in red. Schematic drawing 
generated with MOLMOL38.  
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Figure 3 : The N-src loop of nephrocystin SH3 is twisted by a 
non-canonical proline residue. 
Stereo view of the superimposed backbones of nephrocystin 
(green) and N-Crk SH3 (yellow; PDB: 1CKA). The two structures 
are very similar, with the exception of the N-Src loop, at the 
right. Proline 186, which induces a kink in nephrocystin, is 
shown in red. It corresponds to a position were a semi-
conserved Glu, Asp or Asn residue is found in most SH3 domains. 
 
Figure 4 : Folding of nephrocystin SH3 variants at position 180 
Shown are 1D 1H NMR spectra of wild-type (bottom), L180A 
(center) and L180P (top) nephrocystin SH3 domain (50 mM K-
phosphate pH 6.5, 293K). The shaded bars indicate the random 
coil regions of aliphatic and backbone amide protons, whereas 
the boxed areas indicate the shifted methyl and backbone amide 
resonance regions, characteristic of protein tertiary 
structure. 
 
Figure 5 : Destabilisation of the SH3 fold by the L180 
mutations. 
Left : Sructure of the wild-type nephrocystin SH3. The side 
chains of E156, L180 and K193 are indicated. Right : Model of 
the mutant L180P structure. The diverging type II β-turn which 
fold independently in solution is highligthed in yellow. After 
the molecular dynamics simulation, the major structural change 
was the movement of E156 and K193 side chains, the terminal 
atoms of which come in Van der Waals contact over the 
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pyrrolidine ring of P180 (right panel). This also induced a 
partial disruption of the underlying β-sheet structure. 
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Table I : Structural statistics 
 Average 
Rms deviations from ideal geometry  
Bonds 0.007 Å 
Angles 2.8 deg. 
Impropers 0.3 deg. 
EVdW  -305 kcal/mol 
residues within allowed regions of 
the Ramachandran plot 
94.4 % 
 
Rms deviations from experimental 
restraints 
 
NOE 0.04 Å 
Largest violation 0.3 Å 
Dihedrals 1.3 deg. 
 
Atomic rms differences : 
all structures vs mean structure 
 
backbone 0.63 Å 
all heavy atoms 1.09 Å 
backbone (core SH3) 0.46 Å 
all heavy atoms (core SH3) 0.88 Å 
 
The Van derWaals energies of the refined conformers were 
calculated with X-PLOR, using a cut-off of 7.5 Å . Average 
values of the energies and the r.m.s.d. were calculated over 
the set of 17 conformers (an overlay is shown in Figure 2). For 
structural comparisons, the core SH3 region, corresponded to 
residues 154-165, 169-194, 197-210. 
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